1. DUAL II China: Superior HbA1c reductions and weight loss with insulin degludec/liraglutide (IDegLira) versus insulin degludec in a randomized trial of Chinese people with type 2 diabetes inadequately controlled on basal insulin. Issue 12 (31st August 2021) Authors: Pei, Yu; Agner, Bue R.; Luo, Bin; Dong, Xiaolin; Li, Dongmei; Liu, Jun; Liu, Lei; Liu, Ming; Lu, Yibing; Nishida, Tomoyuki; Xu, Xiangjin; Mu, Yiming Journal: Diabetes, obesity & metabolism Issue: Volume 23:Issue 12(2021) Page Start: 2687 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗